Oral intake of Kluyveromyces marxianus B0399 plus Lactobacillus rhamnosus CECT 30579 to mitigate symptoms in COVID-19 patients: A randomized open label clinical trial
Titel:
Oral intake of Kluyveromyces marxianus B0399 plus Lactobacillus rhamnosus CECT 30579 to mitigate symptoms in COVID-19 patients: A randomized open label clinical trial
Auteur:
Navarro-López, Vicente Hernández-Belmonte, Adriana Pérez Soto, Maria Isabel Ayo-González, Maikel Losa-Rodríguez, Guillermo Ros-Sánchez, Esther Martínez-Gabarrón, Maravillas Sánchez-Pellicer, Pedro Aguera-Santos, Juan Núñez-Delegido, Eva Ruzafa-Costas, Beatriz Picó-Monllor, José Antonio Navarro-Moratalla, Laura